“SPECTRUM AND SEVERITY OF ADVERSE DRUG REACTIONS DURING TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS” (2026) International Research Journal of Pharmacy, 17(9), pp. 11–17. doi:10.56802/cyzkpf46.